Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of ATM-directed antiviral responses by HIV-1 Vif

PLoS Pathogens(2023)10.1371/journal.ppat.1011634Source: DataRank Database

Inhibition of ATM-directed antiviral responses by HIV-1 Vif is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.41)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Adeline M. Luperchio ORCID,Sean P. Riley ORCID,Daniel J. Salamango ORCID,Hoi Tong Wong

Live enrichment

PubMed:37669285 PMC:PMC10503699 OpenAlex:https://openalex.org/W4386453439

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: AI147811

National Institute of General Medical Sciences

Grant: GM136572

NIGMS NIH HHS

Grant: T32 GM136572

NIAID NIH HHS

Grant: K99 AI147811

NIAID NIH HHS

Grant: R00 AI147811

National Institutes of Health

Grant: 2T32GM136572-06

Chemical Biology Training Interface

National Institutes of Health

Grant: 5R00AI147811-04

The Vif-APOBEC Nexus

FWCI

1.41

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011634&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011634&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1011634

journalhttps://doi.org/10.1371/journal.ppat.1011634

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37669285

Fields of Study

HIV Research and TreatmentCytomegalovirus and herpesvirus researchinterferon and immune responses0301 basic medicine03 medical and health sciencesHumansHIV-1NF-kappa BPhosphorylationAntiviral Restriction FactorsHIV SeropositivityAntiviral AgentsAtaxia Telangiectasia Mutated Proteins

MeSH Terms

Antiviral Restriction FactorsAntiviral AgentsHIV SeropositivityHumansPhosphorylationHIV-1NF-kappa BAtaxia Telangiectasia Mutated Proteins

Keywords

BiologyViral replicationCell biologyPhosphorylationImmune systemDNA damageVirusKinaseVirologySignal transductionSimian immunodeficiency virusDNAGeneticsQH301-705.5NF-kappa BAtaxia Telangiectasia Mutated ProteinsRC581-607Antiviral AgentsAntiviral Restriction FactorsHIV SeropositivityHIV-1HumansImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 0: Good health and well-being

Inhibition of ATM-directed antiviral responses by HIV-1 Vif

FAIR Checklist

Authors (4)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)